Application no. and date | 19151416.5 (espacenet) (Federated) (European Patent Register), 20120713 | Patent/reg. no. and date | DK/EP 3517539, 20221214 | Publication date | 20190731 | Priority no. and date | EP 11174266, 20110715, EP 12170055, 20120530 | EP pub. no. and date |
EP 3517539 20190731 | Effective date | | Applicant/owner | Boehringer Ingelheim International GmbH, Binger Strasse 173 55216 Ingelheim am Rhein, DE | Applicant ref. no. | 165860 | Inventor | KLEIN, Thomas, BOEHRINGER INGELHEIM INTERNATIONAL GMBH, Corporate Patents Binger Strasse 173
55216 INGELHEIM AM RHEIN, DE, PFRENGLE, Waldemar, Boehringer Ingelheim International GmbH, Corporate Patents Binger Strasse 173
55216 INGELHEIM AM RHEIN, DE, FRANK, Markus, Boehringer Ingelheim International GmbH, Corporate Patents Binger Strasse 173
55216 INGELHEIM AM RHEIN, DE | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | Opponent | | IPC Class | A61K 31/522 (2006.01) , C07D 473/06 (2006.01) | Title | FARMACEUTISKE SAMMENSÆTNINGER TIL BEHANDLING AF TYPE I OG TYPE II DIABETES | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|